Leukocyte Antigen G (HLA-G) Antibody (FITC)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Leukocyte Antigen G (HLA-G) Antibody (FITC) is a Mouse Monoclonal antibody against Leukocyte Antigen G (HLA-G).
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Leukocyte Antigen G (HLA-G) |
| Host | Mouse |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Monoclonal |
| Conjugation | FITC |
| Isotype | IgG1 |
| Purification | Purified |
| Size 1 | 100 µg |
| Form | Liquid |
| Tested Applications | FCM |
| Buffer | PBS, 1% BSA. Contains sodium azide. |
| Availability | Shipped within 3-7 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P17693 |
| Background | Antibody anti-HLA-G |
| Status | RUO |
| Note | Concentration: 0.1 mg/ml - |
Descripción
Related Products
Human sHLA-G (soluble HLA class I histocompatibility antigen, alpha chain G) ELISA Kit
Ver Producto
HLA-G antibody
Human major histocompatibility complex (MHC) antigens, also referred to as human leukocyte antigens (HLA), are encoded by genes located on the short arm of chromosome 6 (6p21.3). HLA-G is a non-classical MHC class I molecule with multiple immunoregulatory properties. HLA-G exhibits a restricted pattern of expression that includes placental extravillous trophoblasts at the maternal-fetal interface, where it abolishes maternal immune cell activity against fetus and establishes immune tolerance. Aberrant expression of HLA-G has been found in a variety of human neoplastic diseases. It plays an important role in the escape of tumor cells from immunosurveillance.
Ver Producto